INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.22, sa.7, ss.1138-1142, 2012 (SCI-Expanded)
Objective: This study aimed to investigate serum levels of epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), and c-erbB2 in patients with ovarian cancer.